Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)

Sponsor
Augusta University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02115724
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
74
1
2
117
0.6

Study Details

Study Description

Brief Summary

Cardiovascular disease is the leading cause of death in the United States. Other studies have shown that stress, early in life, could be a risk factor for cardiovascular disease, later in life. This study will look at the effect of early life stressors on your cardiovascular health.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Antioxidant cocktail
  • Other: Biopsy
  • Other: Placebo
  • Drug: NMD; 0.4mg sub-lingual nitroglycerin spray
N/A

Detailed Description

This study will have two parts involved to investigate the role that childhood SES status has on cardiovascular health.

Part one: Subjects will give a blood sample which will be processed and analyzed. Flow mediated dilation (FMD) and Pulse wave velocity (PWV/PWA) will be performed at baseline and 2 hours following either a single dose oral antioxidant cocktail (1000 mg of Vitamin C, 600 IU of Vitamin E, and 600 mg of alpha-lipoic acid) or placebo on two days separated by at least 72 hours. Nitroglycerin mediated dilation (NMD, 0.4mg sub-lingual nitroglycerin spray), will be assessed at baseline.

Part two: Subjects, if interested will undergo a subcutaneous gluteal/hip fat biopsy. Micro vessels will be isolated from the adipose tissue and analyzed by pressurized myography for endothelial function and nitric oxide bioavailability.

Study Design

Study Type:
Interventional
Actual Enrollment :
74 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Effect of Low Childhood Socioeconomic Status (SES) on Adult Endothelial Function and Nitric Oxide Bioavailability in Vivo and ex Vivo
Study Start Date :
Apr 1, 2014
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Antioxidant Cocktail

Following an overnight fast, blood samples, flow-mediated dilation, and nitroglycerin mediated dilation (NMD; 0.4mg sub-lingual nitroglycerin spray) will be performed at baseline and 2 hours following either a single dose oral antioxidant cocktail (1000 mg Vitamin C, 600 IU vitamin E, 600 mg Alpha Lipoic Acid) or placebo on two days separated by at least 72 hours.

Dietary Supplement: Antioxidant cocktail
Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment
Other Names:
  • Vitamin C
  • Vitamin E
  • Alpha Lipoic Acid
  • Other: Placebo
    Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment

    Drug: NMD; 0.4mg sub-lingual nitroglycerin spray
    Nitroglycerin mediated dilation will be measured immediately following an administered 0.4mg dose of nitroglycerin spray, sub-lingual.
    Other Names:
  • Generic name: Nitrolingual
  • Manufacturer: Arbor Pharmaceuticals
  • Other: Biopsy

    Following an overnight fast, a subcutaneous gluteal/hip fat biopsy sample will be obtained from each subject under local anesthesia, with adipose tissue (~2x1.5x1.5cm) to be harvested and placed immediately in physiological saline solution (PSS): Small arteries, 100 to 150 um in diameter, will be dissected from the fat under a dissecting microscope, transferred to an arteriographic bath chamber, and cannulated for pressurized myography.

    Other: Biopsy
    Under sterile conditions, a small incision (¼ - ½ inch) by the study doctor will be made and the piece of fat will be taken out. Fat tissue was chosen for this study because it is a big source of small blood vessels which we are studying

    Outcome Measures

    Primary Outcome Measures

    1. Acute Change in Flow mediated dilation [Change from baseline (2 hours)]

      Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment

    Secondary Outcome Measures

    1. Acute Change in Biomarkers of oxidative stress [Change from baseline (2 hours)]

      Nitrite/nitrate, antioxidant capacity, and 8-isoprostane at baseline and 2 hours following acute antioxidant treatment

    2. Acute Change in Arterial Stiffness [Change from baseline (2 hours)]

      Pulse wave velocity will be determined at baseline and 2 hours following acute antioxidant treatment

    3. Acute change in Flow mediated dilation [Immediate]

      Nitroglycerin mediated dilation will be measured immediately following an administered 0.4mg dose of nitroglycerin spray, sub-lingual.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 40 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • documented childhood SES

    • men and premenopausal women ages 18-40

    • lean/overweight/or obese with BMI< or equal to 39kg/m2

    Exclusion Criteria:
    • cardiovascular, renal, pulmonary, hepatic, cerebral, or metabolic,disease

    • use medications that affect vascular tone

    • post menopausal women

    • have class 3 obesity or BMI over 40

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Georgia Prevention Institute , Georgia Regents University Augusta Georgia United States 30912

    Sponsors and Collaborators

    • Augusta University
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Ryan Harris, PhD, Augusta University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ryan Harris, Assistant Professor, Augusta University
    ClinicalTrials.gov Identifier:
    NCT02115724
    Other Study ID Numbers:
    • NO-Stress Pro00001887
    • 5P01HL069999
    First Posted:
    Apr 16, 2014
    Last Update Posted:
    Jul 20, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by Ryan Harris, Assistant Professor, Augusta University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 20, 2022